(0.08%) 5 331.50 points
(0.01%) 40 141 points
(0.11%) 18 657 points
(-0.29%) $79.83
(0.46%) $2.64
(1.27%) $2 448.20
(2.90%) $32.17
(0.25%) $1 092.70
(0.01%) $0.920
(0.00%) $10.68
(0.01%) $0.787
(-0.33%) $90.67
@ $32.54
Issued: 13 Feb 2024 @ 15:42
Return: -10.77%
Previous signal: Feb 12 - 14:47
Previous signal:
Return: -6.62 %
Live Chart Being Loaded With Signals
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States...
Stats | |
---|---|
Today's Volume | 326 815 |
Average Volume | 426 438 |
Market Cap | 1.65B |
EPS | $0 ( 2024-05-07 ) |
Next earnings date | ( $0.240 ) 2024-08-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 12.51 |
ATR14 | $0.0370 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Budur Kumar | Buy | 75 000 | Stock Option |
2024-05-01 | Budur Kumar | Buy | 75 000 | Restricted Stock Units |
2024-03-29 | Kapadia Sandip | Buy | 15 000 | Common Stock |
2024-03-29 | Kapadia Sandip | Sell | 15 000 | Restricted Stock Units |
2024-03-29 | Kapadia Sandip | Sell | 8 013 | Common Stock |
INSIDER POWER |
---|
29.14 |
Last 99 transactions |
Buy: 1 401 408 | Sell: 2 130 732 |
Volume Correlation
Harmony Biosciences Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Harmony Biosciences Correlation - Currency/Commodity
Harmony Biosciences Financials
Annual | 2023 |
Revenue: | $582.02M |
Gross Profit: | $460.79M (79.17 %) |
EPS: | $2.17 |
FY | 2023 |
Revenue: | $582.02M |
Gross Profit: | $460.79M (79.17 %) |
EPS: | $2.17 |
FY | 2022 |
Revenue: | $437.86M |
Gross Profit: | $354.37M (80.93 %) |
EPS: | $3.07 |
FY | 2021 |
Revenue: | $305.44M |
Gross Profit: | $249.92M (81.82 %) |
EPS: | $0.697 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Harmony Biosciences
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators